Literature DB >> 27478862

Quantification of Total and 2-LTR (Long terminal repeat) HIV DNA, HIV RNA and Herpesvirus DNA in PBMCs.

Marta Massanella1, Sara Gianella1, Steven M Lada1, Douglas D Richman2, Matthew C Strain1.   

Abstract

Almost all individuals infected with human immunodeficiency virus (HIV) are also infected with cytomegalovirus (CMV) and Epstein Barr virus (EBV). The aims of our studies have included characterizing and measuring the latent HIV reservoir and understanding the association between asymptomatic replication of CMV (and other herpesvirus, including EBV) and this HIV reservoir (Gianella et al., 2014). This protocol was designed to simultaneously co-extract DNA and RNA from the same peripheral blood mononuclear cell (PBMC) aliquot and quantify HIV, CMV and EBV DNA, as well as HIV RNA using droplet digital PCR (ddPCR). For collection and processing of male genital secretions and quantification of HIV RNA and DNA from seven human herpesviruses from seminal plasma, refer to protocol "Quantification of HIV RNA and Human Herpesvirus DNA in Seminal Plasma" (Vargas-Meneses et al., 2015).

Entities:  

Year:  2015        PMID: 27478862      PMCID: PMC4962884          DOI: 10.21769/bioprotoc.1492

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  9 in total

1.  A quantitative assay for HIV DNA integration in vivo.

Authors:  S L Butler; M S Hansen; F D Bushman
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  PCR-Based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells.

Authors:  C Christopherson; Y Kidane; B Conway; J Krowka; H Sheppard; S Kwok
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract.

Authors:  Sara Gianella; Sheldon R Morris; Christy Anderson; Celsa A Spina; Milenka V Vargas; Jason A Young; Douglas D Richman; Susan J Little; Davey M Smith
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

4.  A novel PCR assay for quantification of HIV-1 RNA.

Authors:  Liang Shan; S Alireza Rabi; Gregory M Laird; Evelyn E Eisele; Hao Zhang; Joseph B Margolick; Robert F Siliciano
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

5.  Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment.

Authors:  Sara Gianella; Marta Massanella; Douglas D Richman; Susan J Little; Celsa A Spina; Milenka V Vargas; Steven M Lada; Eric S Daar; Michael P Dube; Richard H Haubrich; Sheldon R Morris; Davey M Smith
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

6.  Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission.

Authors:  Christine M Rousseau; Ruth W Nduati; Barbra A Richardson; Grace C John-Stewart; Dorothy A Mbori-Ngacha; Joan K Kreiss; Julie Overbaugh
Journal:  J Infect Dis       Date:  2004-10-07       Impact factor: 5.226

7.  Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection.

Authors:  Adrian Schmid; Sara Gianella; Viktor von Wyl; Karin J Metzner; Alexandra U Scherrer; Barbara Niederöst; Claudia F Althaus; Philip Rieder; Christina Grube; Beda Joos; Rainer Weber; Marek Fischer; Huldrych F Günthard
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

8.  Quantification of HIV RNA and Human Herpesvirus DNA in Seminal Plasma.

Authors:  Milenka V Vargas-Meneses; Marta Massanella; Caroline C Ignacio; Sara Gianella
Journal:  Bio Protoc       Date:  2015-05-05

9.  Highly precise measurement of HIV DNA by droplet digital PCR.

Authors:  Matthew C Strain; Steven M Lada; Tiffany Luong; Steffney E Rought; Sara Gianella; Valeri H Terry; Celsa A Spina; Christopher H Woelk; Douglas D Richman
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

  9 in total
  19 in total

1.  Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape.

Authors:  Ross A Pollack; R Brad Jones; Mihaela Pertea; Katherine M Bruner; Alyssa R Martin; Allison S Thomas; Adam A Capoferri; Subul A Beg; Szu-Han Huang; Sara Karandish; Haiping Hao; Eitan Halper-Stromberg; Patrick C Yong; Colin Kovacs; Erika Benko; Robert F Siliciano; Ya-Chi Ho
Journal:  Cell Host Microbe       Date:  2017-04-12       Impact factor: 21.023

2.  Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment.

Authors:  Davey M Smith; Masato Nakazawa; Michael L Freeman; Christy M Anderson; Michelli F Oliveira; Susan J Little; Sara Gianella
Journal:  Clin Infect Dis       Date:  2016-09-06       Impact factor: 9.079

Review 3.  Aging, sex, inflammation, frailty, and CMV and HIV infections.

Authors:  Sean X Leng; Joseph B Margolick
Journal:  Cell Immunol       Date:  2019-11-27       Impact factor: 4.868

4.  Filgotinib suppresses HIV-1-driven gene transcription by inhibiting HIV-1 splicing and T cell activation.

Authors:  Yang-Hui Jimmy Yeh; Katharine M Jenike; Rachela M Calvi; Jennifer Chiarella; Rebecca Hoh; Steven G Deeks; Ya-Chi Ho
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

5.  Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.

Authors:  Aaron Christensen-Quick; Marta Massanella; Andrew Frick; Stephen A Rawlings; Celsa Spina; Milenka Vargas-Meneses; Rachel Schrier; Masato Nakazawa; Christy Anderson; Sara Gianella
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

6.  Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals.

Authors:  Sara Gianella; Antoine Chaillon; Ece A Mutlu; Phillip A Engen; Robin M Voigt; Ali Keshavarzian; John Losurdo; Prachi Chakradeo; Steven M Lada; Masato Nakazawa; Alan L Landay
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

7.  Analytical antiretroviral therapy interruption does not irreversibly change preinterruption levels of cellular HIV.

Authors:  Emmanouil Papasavvas; Steven M Lada; Jocelin Joseph; Xiangfan Yin; Qin Liu; Livio Azzoni; Karam Mounzer; Jay R Kostman; Douglas Richman; Luis J Montaner
Journal:  AIDS       Date:  2018-08-24       Impact factor: 4.177

8.  Replication of Human Herpesviruses Is Associated with Higher HIV DNA Levels during Antiretroviral Therapy Started at Early Phases of HIV Infection.

Authors:  Sara Gianella; Christy M Anderson; Susanna R Var; Michelli F Oliveira; Steven M Lada; Milenka V Vargas; Marta Massanella; Susan J Little; Douglas D Richman; Matthew C Strain; Josué Pérez-Santiago; Davey M Smith
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

9.  The role of CD32 during HIV-1 infection.

Authors:  Lynn N Bertagnolli; Jennifer A White; Francesco R Simonetti; Subul A Beg; Jun Lai; Costin Tomescu; Alexandra J Murray; Annukka A R Antar; Hao Zhang; Joseph B Margolick; Rebecca Hoh; Stephen G Deeks; Pablo Tebas; Luis J Montaner; Robert F Siliciano; Gregory M Laird; Janet D Siliciano
Journal:  Nature       Date:  2018-09-19       Impact factor: 49.962

10.  Subclinical Cytomegalovirus and Epstein-Barr Virus Shedding Is Associated with Increasing HIV DNA Molecular Diversity in Peripheral Blood during Suppressive Antiretroviral Therapy.

Authors:  Antoine Chaillon; Masato Nakazawa; Stephen A Rawlings; Genevieve Curtin; Gemma Caballero; Brianna Scott; Christy Anderson; Sara Gianella
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.